Skip to main content
Log in

Expression of inducible nitric oxide synthase in human cutaneous leishmaniasis

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Cutaneous leishmaniasis (CL) is an infectious disease caused by Leishmania parasite. The expression of inducible nitric oxide synthase (iNOS) and generation of nitric oxide in response to IFN-γ and TNF-α is important in control of infection. The aim of the study was to determine the expression of iNOS in the lesions of Leishmania tropica, and whether there was a correlation between the level of expression and the duration of the disease. Punch biopsy was performed from patients (n = 29) and iNOS immunohistochemical staining was applied. Expression of iNOS protein was detected 82.8% of patients. There was a strong expression with the duration of the disease less than 6 months (p < 0.002). These findings demonstrate that iNOS has a role in L. tropica especially during the early stages of the infection. (Mol Cell Biochem xxx: 147–149, 2005)

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Herwaldt BL: Leishmaniasis. Lancet 354: 1191–1199, 1999

    Article  PubMed  CAS  Google Scholar 

  2. Pearson RD, Sousa AQ: Clinical spectrum of leishmaniasis. Clin Infect Dis 22: 1–13, 1996

    PubMed  CAS  Google Scholar 

  3. Ok UZ, Balcı oglu İC, Ozkan IT, Ozensoy S, Ozbel Y: Leishmaniasis in Turkey. Acta Tropica 84: 43–48, 2002

    Article  PubMed  CAS  Google Scholar 

  4. Ritter U, Moll H: Monocyte chemotactic protein-1 stimulates the killing of Leishmania major by human monocytes, acts synergistically with IFN-γ and is antagonized by IL-4. Eur J Immunol 30: 3111–3120, 2000

    Article  PubMed  CAS  Google Scholar 

  5. Brunet LR: Nitric oxide in parasitic infections. Int Immunopharmacol 1: 1457–1467, 2001

    Article  PubMed  CAS  Google Scholar 

  6. Gantt KR, Goldman TL, McCormick ML, Miller MA, Jeronimo SMB, Nascimento ET, Brintigan BE, Wilson ME: Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi. J Immunol 167: 893–901, 2001

    PubMed  CAS  Google Scholar 

  7. Stenger S, Thuring H, Rollinghoff M, Bogdan C: Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major. J Exp Med 180: 783–793, 1994

    Article  PubMed  CAS  Google Scholar 

  8. Diaz NL, Fernandez M, Figueira E, Ramirez R, Monsalve IB, Tapia FJ: Nitric oxide and cellular immunity in experimental cutaneous leishmaniasis. Clin Exp Dermatol 28: 288–293, 2003

    Article  PubMed  CAS  Google Scholar 

  9. Liew FY, Li Y, Millott S: Tumor necrosis factor (TNF-alpha) in leishmaniasis. II. TNF-alpha-induced macrophage leishmanicidal activity is mediated by nitric oxide from l-arginie. Immunology 71: 556–559, 1990

    PubMed  CAS  Google Scholar 

  10. Qadoumi M, Becker I, Donhauser N, Rollinghoff M, Bogdan C: Expression of inducible nitric oxide synthase in skin lesions of patients with American cutaneous leishmaniasis. Infect Immunol 70: 4638–4642, 2002

    CAS  Google Scholar 

  11. Yaman M, Ozbel Y: The sandflies (Diptera: Psychodidae) in Turkish province of Hatay: some possible vectors of the parasites causing human cutaneous leishmaniasis. Ann Trop Med Parasitol 98: 741–750, 2004

    Article  PubMed  CAS  Google Scholar 

  12. Bogdan C, Rollinghoff M, Diefenbach A: Reactive oxygen and reactive nitrogen intermediates in innate and specific immunity. Curr Opin Immunol 12: 64–76, 2000

    PubMed  CAS  Google Scholar 

  13. Erel O, Kocyigit A, Bulut V, Gurel MS: Reactive nitrogen and oxygen intermediates in patients with cutaneous leishmaniasis. Mem Inst Oswaldo Cruz 94: 179–183, 1999

    Article  PubMed  CAS  Google Scholar 

  14. Serarslan G, Yı ldı rı m HR, Sogut S: Serum antioxidant activities, malondialdehyde and nitric oxide levels in human cutaneous leishmaniasis. Clin Exp Dermatol 30: 267–271, 2005

    Article  PubMed  CAS  Google Scholar 

  15. Niedbala W, Wei XO, Piedrafita D, Xu D, Liew Y: Effects of nitric oxide on the induction and differentiation of Th1 cells. Eur J Immunol 29: 2498–2525, 1999

    Article  PubMed  CAS  Google Scholar 

  16. Berman JD: Human leishmaniasis: clinical, diagnostic, and chemotherapeutic developments in the last 10 years. Clin Infect Dis 24: 684–703, 1997

    PubMed  CAS  Google Scholar 

  17. Herwaldt BI, Berman JD: Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 46: 296–306, 1992

    PubMed  CAS  Google Scholar 

  18. Buates S, Matlashewski G: Treatment of experimental leishmaniasis with the immunomodulators imiquimod and S28463: efficacy and mode of action. J Infect Dis 179: 1485–1494, 1999

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gamze Serarslan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Serarslan, G., Atik, E. Expression of inducible nitric oxide synthase in human cutaneous leishmaniasis. Mol Cell Biochem 280, 147–149 (2005). https://doi.org/10.1007/s11010-005-8542-3

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-005-8542-3

Keyword

Navigation